A whale with a lot of money to spend has taken a noticeably bearish stance on BioNTech.
Looking at options history for BioNTech (NASDAQ:BNTX) we detected 11 strange trades.
If we consider the specifics of each trade, it is accurate to state that 27% of the investors opened trades with bullish expectations and 72% with bearish.
From the overall spotted trades, 6 are puts, for a total amount of $260,100 and 5, calls, for a total amount of $253,556.
What's The Price Target?
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $170.0 to $420.0 for BioNTech over the last 3 months.
Volume & Open Interest Development
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for BioNTech's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of BioNTech's whale activity within a strike price range from $170.0 to $420.0 in the last 30 days.
BioNTech Option Volume And Open Interest Over Last 30 Days
Biggest Options Spotted:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|
| BNTX | CALL | TRADE | BEARISH | 09/16/22 | $260.00 | $97.5K | 111 | 15 |
| BNTX | CALL | TRADE | NEUTRAL | 03/18/22 | $330.00 | $72.0K | 49 | 43 |
| BNTX | PUT | TRADE | BULLISH | 06/17/22 | $170.00 | $54.4K | 103 | 45 |
| BNTX | PUT | TRADE | BEARISH | 01/21/22 | $300.00 | $49.5K | 1.0K | 21 |
| BNTX | PUT | SWEEP | BEARISH | 01/21/22 | $300.00 | $48.0K | 1.0K | 63 |
Where Is BioNTech Standing Right Now?
- With a volume of 1,975,155, the price of BNTX is down -4.88% at $258.21.
- RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.
- Next earnings are expected to be released in 97 days.
What The Experts Say On BioNTech:
- HC Wainwright & Co. has decided to maintain their Buy rating on BioNTech, which currently sits at a price target of $366.
- Morgan Stanley downgraded its action to Equal-Weight with a price target of $294
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you are already an options trader or would like to get started, head on over to Benzinga Pro. Benzinga Pro gives you up-to-date news and analytics to empower your investing and trading strategy.
